Keywords
Hospitalization
Neoplasms
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To characterize the epidemiological profile of hospital admissions and mortality from Leukemias in the state of Maranhão. Methods: This is a descriptive and retrospective cross-sectional study with secondary data on hospital admissions for leukemia in the state of Maranhão (Brazil) and recorded in the Hospital Information System of the SUS of the Department of Informatics of the Unified Health System, between January from 2008 to December 2021. Costs, health regions, deaths, hospitalization rates and mortality rates were evaluated. Results: Maranhão has the second highest number of hospitalizations for leukemia in the Northeast, with 12,169 new hospitalizations in the State in the period studied and the fifth highest mortality rate for this neoplasm in the country. The prevalence of cases depends on factors such as age, sex, ethnicity and subtype of leukemia. With regard to the profile of the patients, the majority are male (62.8%) compared to females (37.2%) and the most frequent age group comprises 1 to 19 years (72%). Conclusion: Hospitalizations for leukemia in Maranhão account for a large number of cases and mortality, representing an important public health issue, however, few specific studies collaborate to deepen the theme.
References
AGAIAN S, et al. Automated screening system for acute myelogenous leukemia detection in blood microscopic images. IEEE Systems journal, 2014; 995-1004.
AMERICAN CANCER SOCIETY (EUA). Leukemia in Children. 2021. Disponível em: https://www.cancer.org/cancer/leukemia-in-children.html. Acessado em: 28 de março de 2022.
BEWESDORF JP, et al Healthcare expenses for treatment of acute myeloid leukemia, Expert Review of Hematology. 2019; 12:8, 641-650.
BRASIL, Ministério da Saúde. Banco de dados do Sistema Único de Saúde – DATASUS, Informações de Saúde, Morbidade Hospitalar do SUS (SIH/SUS). Disponível em: https://datasus.saude.gov.br/acesso-a-informacao/morbidade-hospitalar-do-sus-sih-sus/. Acessado em: 30 de abril de 2022.
BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde – SAS. Instituto Nacional do Câncer José Alencar Gomes da Silva. Coordenação de Prevenção e Vigilância. Estimativa 2020: incidência de câncer no Brasil. Rio de Janeiro: INCA, 2019. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2020-incidencia-de-cancer-no-brasil.pdf. Acessado em: 30 de março de 2022.
BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde. Portaria nº 840 de 8 de setembro de 2014. Aprova as Diretrizes Diagnósticas, Terapêuticas da Leucemia Mieloide Aguda em Crianças e Adolescentes. Nº 174 – DOU – 10/09/14 – seção 1 – p.71
BRAY F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin., 2018; 68(6): 394-424.
DOMINGUEZ, R, et al. Morbimortalidade por doenças oncohematológicas no Brasil entre 2002 e 2016. Revista Eletrônica Acervo Saúde, 2020; 12(10): e3795.
HOFFBRAND AV, MOSS PAH. Fundamentos em hematologia de Hoffbrand. 7. ed. Porto Alegre: Artmed Editora, 2018; 384p.
INSTITUTO NACIONAL DO CÂNCER (INCA). Estatísticas de câncer. Ministério da Saúde, 2021. Disponível em: https://www.inca.gov.br/numeros-de-cancer. Acessado em: 30 de março de 2022.
INSTITUTO NACIONAL DO CÂNCER (INCA). Estimativa 2020: Síntese de resultados e comentários. Ministério da Saúde, 2020. Disponível em: https://www.inca.gov.br/estimativa/sintese-de-resultados-e-comentarios. Acessado em: 30 de março de 2022.
INSTITUTO NACIONAL DO CÂNCER (INCA). Incidência, mortalidade e morbidade hospitalar por câncer em jovens, adolescentes e adultos no Brasil: informações dos nascimentos de câncer e do sistema de mortalidade. Rio de Janeiro: Instituto Nacional de Câncer José Alencar Gomes da Silva; 2016, 412 pág. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//incidencia-mortalidade-morbidade-hospitalar-por-cancer.pdf. Acessado em: 30 de março de 2022.
JULIUSSIN G, HOUGH, R. “Leukemia.” Progress in tumor research, 2016; 43: 87-100.
ORGANIZAÇÃO MUNDIAL DE SAÚDE (OMS). OMS afirma que COVID-19 é agora caracterizada como pandemia. 2020. In: OPAS Organização Pan americana de saúde. Disponível em: https://www.paho.org/pt/news/11-3-2020-who-characterizes-covid-19-pandemic. Acessado em: 30 de março de 2022.
PEDREIRA CE, et al. New decision support tool for treatment intensity choice in childhood acute lymphoblastic leukemia. IEEE Transactions on Information Technology in Biomedicine, 2008; 284-290.
SMITHERMAN AB, et al. Early Posttherapy Hospitalizations Among Survivors of Childhood Leukemia and Lymphoma. J Pediatr Hematol Oncol., 2016; 38(6):4 23-8.
SUNG H, et al. Global Cancer Statistics 2020: GLOBOCAN. Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 2021; 71 (3): 209-249.
WORLD HEALTH ORGANIZATION. Internacional Agency for Research on Cancer. Leukaemia – Source: Globocan 2020. The Global Cancer Observatory, 2020. Disponível em: https://gco.iarc.fr/today/data/factsheets/cancers/36-Leukaemia-fact-sheet.pdf. Acessado em: 25 de janeiro de 2023.
ZAGO MA, et al. Tratado de Hematologia. 1. ed. Rio de Janeiro: Atheneu, 2013; 900p.